You have read all your free articles, to continue reading subscribe to read the rest of this content.
In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer is published in the Pancreas scientific journal. The results demonstrate that Biovica’s DiviTum assay can provide an accurate prognosis and evaluation of treatment efficacy. The proofAlready a subscriber Login You have read all your free…
Follicum announces that significant progress has been made in the company's development of new drug treatments for diabetes and other diseases. Within the framework of a preclinical research project, the interaction between one of Follicum's tissue-repairing peptide families and a specific receptAlready a subscriber Login You have read all your…
Atrogi has received approval from the German authority BfArM to initiate a phase 1 study with their small molecule drug candidate ATR-258 in healthy volunteers and type 2 diabetics. The trial is expected to be completed by year end 2022 with the final report in Q1/2,2023. “Following extensivAlready a subscriber…
Nordic Nanovector announces that the first patient has been enrolled into one of the two new arms of its expanded Lymrit 37-01 clinical study with Betalutin. Betalutin is a novel anti-CD37 targeting Antibody Radionuclide Conjugate in development for the treatment of major types of non-Hodgkin’sAlready a subscriber Login You have…
